iXensor
Dr. Fitzgerald is a Professor of Medicine, Emeritus at Stanford Medical School, and a veteran in venture capital with a focus on medical device, digital health, and biotechnology. He co-founded Latterell Venture Partners, TriVentures, and TransPacific Venture Partners and has tremendous experience in transitioning start-ups toward the ideal next stages.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
iXensor
iXensor is a new generation health technology company that integrates medical engineering, biochemistry, and information technology expertise to develop the PixoTech® platform for connected smart healthcare. Based on it, iXensor created PixoTest®, the world first FDA approved smartphone camera-based blood test system for health care in 2017. After iXensor Co. Ltd. was founded in Taipei, Taiwan in 2012 by Alan Tsai, Jerry Chen, and Carson Chen, this breakthrough mobile health solution sparked global interest and attention. The iXensor family consists of 5 Ph.D. and over 40 energetic and talented professionals who are devoted to providing innovative and reliable Point-of-care testing (POCT) solutions. Based on our PixoTech® platform, the smart sensing technology for connected healthcare, we have developed a wide range of professional In-Vitro Diagnostics and end-user self-test products. iXensor received several international awards, including the 2014 MEDICA eHealth Innovation Award, 2017 Digital Health Award, 2017 Japan Good Design, 2018 CES Best BabyTech Award, and 2019 German Design Award.